OREXIGEN THERAPEUTICS (Stock Symbol: OREX)
OREX- Stock Profile
| Tweet |
| Company Name: | OREXIGEN THERAPEUTICS |
| Stock Ticker (Symbol): | OREX |
| Traded Exchange: | NASDAQ Stock Exchange |
| Average Traded Price: | $6.16 |
| Average Daily Traded Volume: | 781,100 |
| Started to Trade on: | Monday, April 30, 2007 |
OREXIGEN THERAPEUTICS Profile
Orexigen Therapeutics, Inc., a biopharmaceutical company, focuses on the development of pharmaceutical product candidates for the treatment of obesity. Its lead combination product candidates include Contrave, which has completed Phase III clinical trials; and Empatic that has completed Phase II clinical trials. Contrave is a combination of two drugs, bupropion and naltrexone, in a sustained release formulation (SR). Bupropion is an antidepressant and smoking cessation medication; naltrexone is a treatment for alcohol and opioid addiction. The company's Empatic product candidate is a combination of bupropion SR and zonisamide SR. Zonisamide, in an immediate release formulation for the adjunctive treatment of partial seizures, a form of epilepsy. The company was founded in 2002 and is based in La Jolla, California.
| OREX Charts | OREX Quotes | OREX Analysis | OREX Price Calculators | OREX Volume Calculators | OREX Volatility Calculators |
You are logged Out of the Members' Area
To have access to real-time quotes, charts, trading signals and fresh market outlook you have to be logged in:
Not a member yet?
Click here to become a full member of MarketVolume® and enjoy the benefits of a feature rich
market timing system!
No, Thanks, I would like to check the website first.